Status:
COMPLETED
Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin
Lead Sponsor:
Minneapolis Heart Institute Foundation
Collaborating Sponsors:
The Medicines Company
Conditions:
Non-STEMI Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
This is a registry of patients with non ST segment elevation Myocardial Infarction (heart attack) and/or unstable acute coronary artery syndrome treated with a standardized protocol including Bivaliru...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Chest pain or symptoms believed to be an anginal equivalent and representing myocardial ischemia, lasting at least 10 minutes within the past 24 hours
- Having any one of the following:
- Ischemic changes on ECG: ST depression \>0.5 mm OR T wave inversion \>2 mm
- Positive cardiac markers
- New onset CHF presumed secondary to ischemia
- Pulmonary edema
- Known coronary artery disease with typical symptoms
- Hemodynamic instability
- Sustained ventricular tachycardia
Exclusion
- For the purpose of the SSDI, patients will be excluded if we are unable to obtain their Social Security Number.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00842374
Start Date
December 1 2008
End Date
December 1 2012
Last Update
April 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ridgeview Medical Center
Waconia, Minnesota, United States, 55387